Loading clinical trials...
Loading clinical trials...
A phase IV, randomized, single-blind, single-center study measuring the effects of Pecs II block with 0.25% bupivacaine versus surgeon infiltration with 0.25% bupivacaine on postoperative pain control...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
NYU Langone Health
NCT07057037 · Rotator Cuff Tear, Labral Tear, and more
NCT06477965 · Chronic Pain, Osteoarthritis, Knee, and more
NCT03984955 · Tennis Elbow, Lateral Epicondylitis, and more
NCT07030972 · Bicipital Tendonitis
NCT07483320 · Achilles Injuries Tendon, Achilles Tendinopathy (AT), and more
NYU Langone Health
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions